Edit

COVID-19 Updates

About us

The Institut Pasteur du Cambodge (IPC) is a Cambodian non-profit research institution. In 1992, the IPC was re-opened based on an agreement with the Royal Government of Cambodia (RGC) and the Institut Pasteur (IP, Paris, France) that was renewed in 2013. The IPC operates under the senior patronage of the Cambodian Ministry of Health (MoH), on behalf of which, it carries out life sciences and health research as well as public services and training activities. 

The Institut Pasteur du Cambodge (IPC) is a Cambodian non-profit research institution. In 1992, the IPC was re-opened based on an agreement with the Royal Government of Cambodia (RGC) and the Institut Pasteur (IP, Paris, France) that was renewed in 2013. The IPC operates under the senior patronage of the Cambodian Ministry of Health (MoH), on behalf of which, it carries out life sciences and health research as well as public services and training activities. 

The IPC plays a major role in life sciences and health research against emerging infectious diseases (human/animal) in cooperation with national and international partners. The IPC is a member of the Institut Pasteur International Network (IPIN, 32 institutions). In addition, following the 1992 agreement with the RGC and IP (Paris), together with HE Prof. MAM Bunheng, Cambodian Minister of Health, Prof. Stewart COLE, General Director of the Institut Pasteur (Paris) is the co-chair of IPC annual administrative board. As of January 2021, the IPC Directorate is composed of an Executive Director, Dr. Laurence BARIL (International Technical Expert from the French Ministry of Europe and Foreign Affairs), a Deputy Director, Dr. LY Sowath (MoH and IPC senior researcher), and a Chief Financial Officer, Mr. Christophe MOUSSET (IP, Paris).

 

The IPC is composed of several entities: an administrative and financial department (including lab maintenance and metrology), several public services (Medical Biology Laboratory (LBM), Laboratory for Environment and Food Safety (LEFS), International Vaccination Center, three rabies prevention centers (Phnom Penh, Kampong Cham and Battambang)), five research units (Immunology, Entomology, Virology, Malaria, and Epidemiology/Public Health) and four research groups (AMR/TB, Clinical Research, One Health and Geohealth) and a Metrology shared service. The IPC hosts permanent local researchers (n = 8) and 9 international researchers seconded from Institut Pasteur (Paris, n = 6), French National Research Institute for Sustainable Development (IRD, n = 2) and French Agricultural Research for Development (CIRAD, n= 1). In addition, several senior researchers and post-doctorates are working on specific projects. As of December 2020, 32 scientists are present on the campus for a total staff of around 290 people (14 nationalities).  The IPC benefits from the support of several international cooperation and development partners to ensure its missions. 

 

The IPC is also involved in post-graduate-level training. Each year, the IPC hosts around 100 students in the areas of biomedical sciences and engineering, as well as master and doctoral students in life sciences from different universities based in Cambodia and in other countries. The IPC is also a first line partner of the International Masters for Infectiology from the University of Health Sciences (UHS, Phnom Penh) and University Paris-Saclay (France).

 

The IPC’s laboratories are among the most efficient in Cambodia and Southeast Asia (SEA) for the diagnosis and study of pathogen transmission, analyses of biological and genetic markers for severity or antimicrobial resistance (AMR), human/animal infectious disease prevention and clinical research.

Dr. Laurence BARIL

IPC Director

Dr. Laurence Baril has ended her mission at the Institut Pasteur du Cambodge mid-July 2021. Dr. Ly Sowath is the Acting Director until the arrival of the successor of Dr. Laurence Baril.

Established in 1953 and re-opened in 1992, the Institut Pasteur du Cambodge (IPC) is a research institution operating under the auspices of the Cambodian Ministry of Health (MoH) and the Institut Pasteur (IP, Paris, France). The IPC’s missions are to conduct high-quality and innovative life sciences and health research on infectious and emerging diseases in Cambodia, to provide environmental and food safety, vaccination and medical biology services to the public, and the IPC also contributes to training medical doctors, pharmacists, veterinarians, engineers, masters and PhD students in biological sciences from Cambodia and internationally. As a member of the Institut Pasteur International Network (IPIN, 32 institutions), the IPC benefits from the dynamic network where 10 institutions are based in the Asia-Pacific region from Iran to New Caledonia.

The IPC focuses its research and public health activities on controlling communicable diseases in partnership with hospitals, specialized Cambodian centers from MoH (CDC, NIPH, CENAT, NCHADS, CNM…), the Ministry of Agriculture, Forestry and Fishery (MAFF), and the main universities based in Cambodia (UHS, ITC, RUPP, RUA, UP etc.). The IPC welcomes students and fellows from Cambodia and from all around the world.

 

There is still the need for high-quality and innovative research on rabies, tuberculosis, HIV, hepatitis, dengue fever and other vector-borne diseases and emerging viruses, which continue to drive high morbidity and mortality in Cambodia. In addition, the fight against bacterial infections (including tuberculosis) is compromised by the increase in antimicrobial resistance (AMR). If malaria is declining, drug-resistant parasites are present. All those topics require that the IPC continue to develop its research activities to serve the population living in Cambodia and in the Greater Mekong Sub-region (GMS).

 

As part of its research and public health mission, the IPC hosts several national and international reference laboratories for a number of pathogens (influenza, rabies, dengue/arboviruses, COVID-19 etc.) and several research programs are in place to identify, diagnose, and sequence numerous other emerging pathogens including zoonotic diseases. Since 2008, in response to the need for a bio-safe and bio-secured facility to handle biological samples from dangerous and/or unknown pathogens, the IPC is equipped with the first and only high level biosafety (BSL-3) laboratory platform in Cambodia. Thanks to the support from development partners or through research projects, the IPC is upgrading its equipment on the BLS-3 platform and, in 2021, will create a mini-sequencing platform.

 

The COVID-19 pandemic perfectly illustrates the importance of the IPC at a national, regional and international level. As of January 2020, at the request of the Cambodian MoH, using our BLS-3-level capacity together with diagnostic test development expertise, the IPC has implemented, validated, and ensured diagnostic capacity to identify COVID-19 cases in Cambodia. The IPC has also supported the Cambodian CDC in charge of the national response coordination for COVID-19 with IPC competencies in data management system and epidemiology. Therefore, from January to May 2020, the IPC was the only laboratory for COVID-19 diagnosis and identification in Cambodia.

 

Since June 2020, NIPH is actively contributing to this COVID-19 diagnostic effort and other laboratories should be equipped before mid-2021. By the end of 2020, the IPC has completed almost 200,000 PCR tests for COVID-19 for the MoH, and has contributed to COVID-19 case investigations by providing its expertise in performing and interpreting serologies and virus culture and sequencing.

 

The Virology Unit has also successfully cultured and sequenced the virus (SARS-CoV-2) from clinical samples of infected patients. This will contribute to the global efforts in diagnosis, vaccine and drug development against this new zoonotic disease. In April 2020, the World Health Organization (WHO) designated the IPC as one of WHO Global Referral Laboratory against COVID-19. The WHO COVID-19 Referral Laboratory Network is comprised of laboratories able to provide confirmatory testing for COVID-19 and to accelerate new technology (testing and equipment) validation such as vaccines and drugs as they become available. This is an important recognition for the IPC and for Cambodia.

 

We would like to thank the Royal Government of Cambodia (RGC), the MoH, WHO, national and international development partners, and private donors for their trust and support to the IPC in the fight against COVID-19. That financial support has helped the IPC to face the multiple challenges due to this sanitary crisis and to support the Cambodian MoH on a daily basis. It is now necessary to combine diagnostic and surveillance efforts to research efforts against this new virus, to understand its transmission modes and the immune response in humans and animals. This is achievable only through high excellence in scientific collaborations. It is also critical to be well prepared for the next new pathogen emergencies and to continue the high excellence research for the other known pathogens.

 

The IPC team, fully aware of the challenges and responsibilities, are wholly committed, with its partners and the International Pasteur Institutes Network (IPIN), to sharing its values for innovation, solidarity, passion, responsibility and multiculturalism, to understand and combat emerging infectious diseases in order to enable all Cambodians to benefit from the best possible health and well-being.

IPC History

December 1953 IPC's History
January 1958 IPC's History
1986 - 1994 IPC's History
August 27, 1992 IPC's History
March 29, 1994 IPC's History
February 10, 1995 IPC's History
March 11, 2013 IPC's History

IPC History

December 1953 IPC's History
January 1958 IPC's History
1986 - 1994 IPC's History
August 27, 1992 IPC's History
March 29, 1994 IPC's History
February 10, 1995 IPC's History
March 11, 2013 IPC's History

Main National Partners

Main International Partners